Back to search
SECONDARY PULMONARY HYPERTENSION
Clinical trial pipeline · Data from ClinicalTrials.gov
See which SECONDARY PULMONARY HYPERTENSION trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which SECONDARY PULMONARY HYPERTENSION trials you may qualify forBackground: One way to treat liver cancer is to deliver chemotherapy drugs only to the liver (and not to the whole body). Researchers want to see if adding the…
TX000045-003 is a double-blind, randomized, parallel group, placebo-controlled, proof- of-concept (POC) study, evaluating 2 dose regimens of TX000045 over the c…
Pulmonary hypertension secondary to left heart disease is associated with increased morbidity and mortality, particularly in patients with rheumatic chronic val…
At present, the first-line treatment for patients with advanced unresectable intrahepatic cholangiocarcinoma is mainly systemic treatment, but the improvement i…
This study will examine and test healthy volunteers and patients with pulmonary hypertension to try to learn more about the disease and find better ways to dete…
PH-HFpEF patients will receive open-label doses of levosimendan and be periodically evaluated for safety in extended use.
The purpose of this study is to determine how often people with sickle cell anemia develop pulmonary hypertension a serious disease in which blood pressure in t…